Home » Blog » Great News In Freedom From Menopause Malaise

Great News In Freedom From Menopause Malaise

“It’s hands down the biggest screwup of the medical field in the last 25 years.” ~ Bestselling author, Dr. Peter Attia, referring to the bungling of research that turned a generation of women off hormone replacement therapy.

This lack of hormone replacement has been a tragedy for women who have suffered the resulting broken bones, increased cancer, incontinence, heart attacks, dementia, and early death.

Fortunately, this massive medical mistake is now turning around, and in a big way. This is VERY GOOD NEWS for women, who can now enjoy the benefits of longer, healthier, more mentally alert lives with estrogen and progesterone. A massive study of nearly 11 million women now adds more conclusive evidence of the benefits of hormone replacement for those women who need it.

Check out the two following videos with expert doctors discussing the benefits of HRT. Below these is a link to research showing the benefits of HRT, including a death rate that is HALF that for women who did NOT take hormone therapy.

“The longer you’re exposed to estrogen, the lower your risk for cognitive disorders.” ~ Dr. Mary Claire Haver

Estrogen Saves Lives

A 2024 study of 10,944,328 women showed that those who took estrogen replacement therapy lived longer, healthier, fitter lives. The death rate for those who did NOT take hormone therapy was nearly twice the rate of those who had hormone therapy. (12.6 vs 6.3 per 1,000 person-years) (Table 2). Furthermore, estrogen replacement therapy protected women against disease. “The use of estrogen monotherapy beyond age 65 years was associated with significant risk reductions in mortality (19% or adjusted hazards ratio, 0.81; 95% CI, 0.79-0.82), breast cancer (16%), lung cancer (13%), colorectal cancer (12%), congestive heart failure (CHF) (5%), venous thromboembolism (3%), atrial fibrillation (4%), acute myocardial infarction (11%), and dementia (2%).

This study, published in the Journal of the North American Menopause Society, overturns the previous negative views on hormone replacement therapy (HRT) for women over the age of 65. The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia.

Baik, Seo H. PhD; Baye, Fitsum MS; McDonald, Clement J. MD. Use of menopausal hormone therapy beyond age 65 years and its effects on women’s health outcomes by types, routes, and doses. Menopause 31(5):p 363-371, May 2024. | DOI: 10.1097/GME.0000000000002335

References

Bluming, Avrum and Carol Tavris “Estrogen Matters: Why Taking Hormones in Menopause Can Improve Women’s Well-Being and Lengthen Their Lives.”

Dr. Bluming, an oncologist, and Dr. Tavris, a social psychologist, challenge the prevailing medical narrative surrounding hormone replacement therapy (HRT) for menopausal women. They argue that the fear and backlash against estrogen therapy, particularly after the Women’s Health Initiative (WHI) study, have been overblown and that estrogen replacement therapy can provide significant benefits for women’s health and well-being.

“Estrogen Matters” advocates for a personalized approach to hormone therapy, emphasizing the importance of individualized treatment decisions based on a woman’s medical history, risk factors, and preferences. The book encourages women to have informed discussions with their healthcare providers about the potential benefits and risks of estrogen therapy and to consider its potential impact on their overall health and longevity.

What is the WW?

Leave a Reply

Your email address will not be published. Required fields are marked *